Abiopharma

Clearmind Medicine Welcomes President Trump’s Executive Order as a Historic Catalyst for Psychedelic Innovation and Veteran Mental Health Care

FONAR Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of FONAR Corporation - FONR

Report of Periodic or Interim Report

FibroBiologics Compliant with All Nasdaq Listing Requirements

AGNC Investment Corp. Announces First Quarter 2026 Financial Results

Semrush Unveils Brand Visibility Framework at Adobe Summit

Definium Therapeutics Announces New Employee Inducement Grants

Allegiant Announces Future Board Composition Following Sun Country Acquisition

Spruce Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Second Quarter Results